These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 3052079

  • 1. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN, Ellingson AB, Kotlik A, Tsibris JC.
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T, Lindheim SR, Duffy DM, Vijod MA, Stanczyk FZ, Lobo RA.
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months.
    Spellacy WN, Ellingson AB, Kotlik A, Tsibris JC.
    Contraception; 1988 Jul; 38(1):27-35. PubMed ID: 3139358
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE, Doose DR, Walker SA, Nayak RK.
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS, Ayerst RI, Harris JW, Stone RA, Anderson AE, Jones TL, Curtis MK.
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [Abstract] [Full Text] [Related]

  • 17. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [Abstract] [Full Text] [Related]

  • 18. Contraception for women with diabetes: an update.
    Skouby SO, Mølsted-Pedersen L, Petersen KR.
    Baillieres Clin Obstet Gynaecol; 1991 Jun 15; 5(2):493-503. PubMed ID: 1954724
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
    Spellacy WN, Tsibris JC, Hunter-Bonner DL, Smalling S, Chez RA, Angel JL, O'Brien WF.
    Contraception; 1992 Jun 15; 45(6):533-9. PubMed ID: 1617962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.